Page last updated: 2024-10-28

hypericin and Diabetes Mellitus, Adult-Onset

hypericin has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Alzheimer's disease (AD) and type 2 diabetes (T2D) are two of the most common diseases in elderly population and they have a high rate of comorbidity."1.91Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. ( Gao, LH; Ma, QH; Wang, J; Yan, F; Yuan, X, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yuan, X1
Yan, F1
Gao, LH1
Ma, QH1
Wang, J1
Liang, C1
Hao, F1
Yao, X1
Qiu, Y1
Liu, L1
Wang, S1
Yu, C1
Song, Z1
Bao, Y1
Yi, J1
Huang, Y1
Wu, Y1
Zheng, L1
Sun, Y1
Wang, G1
Yang, X1
Yang, S1
Sun, L1
Li, Y1

Other Studies

2 other studies available for hypericin and Diabetes Mellitus, Adult-Onset

ArticleYear
Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning.
    CNS neuroscience & therapeutics, 2023, Volume: 29, Issue:11

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Diabetes Mellitus, Type 2; Drug Repositioning; Human

2023
Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.
    International journal of biological sciences, 2019, Volume: 15, Issue:7

    Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Cell Line; Cell Survival; Diabetes Mellitus, Type 2;

2019